Berlin/Cologne/Hamburg, March 08, 2021 – PCR tests are the most reliable method for diagnosing Corona infection. Health offices and physicians […]
Alacris Theranostics startet Seedmatch-Crowdfunding-Kampagne für einzigartige computergestützte Tumoranalyse zur Optimierung von KrebstherapienJeder Mensch ist anders und Tumore besonders – ein
European Commission supports DigiTwins On Friday, 18th of May, DigiTwins received an invitation from the European Commission to enter the
New biomarkers for bowel cancer treatment Scientists can predict in the lab whether a drug will be effective for individual
The quality management of Alacris Theranostics GmbH has been certified by TÜV Süd according to ISO 9001:2015. Alacris therefore fulfills
An international group of scientists from 6 countries bring together their expertise to develop a combined experimental and systems biology
Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments Berlin, 29th July
The Deutsche Innovationspreis 2015 was awarded in Munich on Friday, April 24th. Alacris is the proud winner in the category
Alacris is one of the partners of CANCER-ID, a newly formed European consortium funded by the Innovative Medicines Initiative (IMI).
